Nelson, Christopher E.
Wu, Yaoying
Gemberling, Matthew P.
Oliver, Matthew L.
Waller, Matthew A.
Bohning, Joel D.
Robinson-Hamm, Jacqueline N.
Bulaklak, Karen
Castellanos Rivera, Ruth M.
Collier, Joel H.
Asokan, Aravind
Gersbach, Charles A. http://orcid.org/0000-0003-1478-4013
Article History
Received: 7 August 2018
Accepted: 21 December 2018
First Online: 18 February 2019
Competing interests
: J.N.R.-H., C.E.N. and C.A.G. have filed patent applications related to genome editing for Duchenne muscular dystrophy. C.A.G. is an advisor for Sarepta Therapeutics, and a co-founder of and advisor for Element Genomics and Locus Biosciences. A.A. is a co-founder of and advisor for StrideBio.